Zambia: Is the US trading HIV treatment for minerals?

The intersection of humanitarian aid and resource extraction has emerged as one of Africa's most contentious geopolitical battlegrounds. Zambia's recent standoff with Washington over critical minerals access—reportedly contingent on continued reliance on US-funded HIV, tuberculosis, and malaria programmes—illustrates a shifting power dynamic that European investors must understand as they compete for African mineral rights and market access.

Zambia sits atop substantial reserves of cobalt, copper, and lithium—minerals essential for the global energy transition. With demand for battery metals projected to triple by 2035, major powers are competing intensely for supply security. The US approach appears to leverage its dominant role in funding Zambia's health infrastructure: approximately 40% of Zambia's HIV treatment programmes depend on American funding, creating structural economic dependency that extends beyond health into political negotiation.

The reported conditioning—whether explicit or implicit—represents a calculated strategy. The US seeks to secure reliable mineral supply chains outside of Chinese influence (which currently dominates African cobalt and lithium processing). However, this approach carries significant risks for Washington's long-term credibility and creates strategic opportunities for alternative partners, particularly the EU.

For European investors, this dynamic presents three critical implications. First, Zambia's hesitation to agree to US terms suggests receptiveness to alternative partnerships. European companies and governments offering health infrastructure investment *without* mineral conditionality could establish preferential access to Zambian resources. The EU's approach to critical minerals strategy—emphasised in its recent Critical Raw Materials Act—explicitly avoids the transactional model the US appears to employ.

Second, the situation underscores Zambia's broader economic vulnerability. The country faces significant debt distress and currency pressure; its copper revenues alone cannot sustain development needs. Investors should recognise that any partner offering integrated solutions—health infrastructure financing combined with transparent mineral exploration frameworks—holds substantial negotiating advantage. European pension funds and impact investors are well-positioned to structure deals combining development finance with resource rights.

Third, this episode reveals cracks in the Western consensus on Africa engagement. If the EU can position itself as a principled partner rejecting coercive resource diplomacy, it captures moral and practical advantage. Zambian policymakers are increasingly sophisticated; they understand the difference between partnership and exploitation. European investors who demonstrate genuine long-term commitment to Zambian development—beyond extractive interests—build durable relationships competitors cannot easily disrupt.

The minerals themselves remain critical: cobalt prices have surged 35% in 18 months as EV demand accelerates. A barrel of oil equivalent in battery metals now commands premium valuations. Zambia's estimated 4.2 million tonnes of cobalt reserves represent roughly 8% of global supply. Control over such assets justifies serious investment in relationships and credibility.

However, investors should note Zambia's regulatory environment remains unpredictable. Recent contract renegotiations with mining companies signal government eagerness to capture greater resource rents—a reasonable position given historical extraction patterns. European investors entering this market must prepare for tougher negotiations but can position themselves as more flexible partners than either US or Chinese competitors.